Related Experiment Video
Updated: Dec 26, 2025

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
[Sexual dysfunction in patients with chronic prostatitis and its treatment]
1FGBOU VO Academician Ye. A. Vagner Perm State Medical University of the Ministry of Healthcare of the Russian Federation, Perm, Russia.
Sexual disorders like premature ejaculation are common in chronic prostatitis (CP). A combination of Vitaprost and NeuroDose effectively treated these dysfunctions in 94.3% of patients, improving sexual function and quality of life.
Area of Science:
- Urology
- Andrology
- Sexual Medicine
Background:
- Chronic prostatitis (CP) frequently leads to sexual disorders.
- Common sexual dysfunctions include premature ejaculation and decreased orgasm intensity.
Purpose of the Study:
- To determine the prevalence and types of sexual disorders in CP patients.
- To assess the efficacy of Vitaprost and NeuroDose in treating these sexual dysfunctions.
Main Methods:
- A two-stage study involving 422 CP patients.
- Utilized questionnaires (Loran-Segal, IIEF-5) and clinical assessments.
- Second stage involved 244 patients treated with Vitaprost and NeuroDose for two months.
Main Results:
- Sexual disorders were present in 77% of CP patients, primarily premature ejaculation and decreased orgasm intensity.
- Vitaprost and NeuroDose therapy resulted in a 94.3% effectiveness rate.
- Significant improvements observed in male copulative function, sexual intercourse duration, orgasm intensity, and reduced neuropsychiatric symptoms.
Conclusions:
- Premature ejaculation and decreased orgasm intensity are prevalent in CP.
- Combination therapy with Vitaprost and NeuroDose demonstrates high efficacy for treating sexual dysfunction in CP patients.
More Related Videos
09:49Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
Published on: December 28, 2021
09:49Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation
Published on: August 13, 2015
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Nursing Assessment of the Genitourinary System I: Health History
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...